Sign In to Follow Application
View All Documents & Correspondence

Combination Of Small Molecule Cd 47 Inhibitors With Other Anti Cancer Agents

Abstract: The present invention relates to a composition comprising of a CD47-SIRPa blocking agent and one or more anti-cancer agent(s): wherein the CD47-SIRPa blocking agent is represented by compound of formula (I). The present invention also relates to a method of treating cancer in a subject by administering therapeutically effective amount of CD47-SIRPa blocking agent represented by formula (I) in combination with one or more anti-cancer agent(s).

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
02 June 2021
Publication Number
26/2021
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
shamim_a@aurigene.com
Parent Application

Applicants

AURIGENE ONCOLOGY LIMITED
39-40, KIADB Industrial Area, Electronic City Phase II, Hosur Road Bangalore 560100 India

Inventors

1. RAMACHANDRA, Muralidhara
V173, Adarsh Palm Retreat, Outer Ring Road, Bellandur Post Bangalore 560103
2. SASIKUMAR, Pottayil Govindan Nair
# 5, Deccan Palms, Ananth Nagar Phase II, Electronic City Post Bangalore 560100
3. DAGINAKATTE, Girish Chandrappa
# 2002, Sobha Daffodil Apts, HSR Layout sector 2 Bangalore 560102
4. BALKUDRU, Kiran Aithal
#149, “Jyothi”, 7th Main, 5th Cross Nobonagar Sector 2, Bannerghatta Road Bangalore 560076

Specification

Documents

Application Documents

# Name Date
1 202147024578-FORM 1 [02-06-2021(online)].pdf 2021-06-02
2 202147024578-DRAWINGS [02-06-2021(online)].pdf 2021-06-02
3 202147024578-COMPLETE SPECIFICATION [02-06-2021(online)].pdf 2021-06-02
4 202147024578-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [02-06-2021(online)].pdf 2021-06-02
5 202147024578-ENDORSEMENT BY INVENTORS [17-06-2021(online)].pdf 2021-06-17
6 202147024578-Proof of Right [05-07-2021(online)].pdf 2021-07-05
7 202147024578-Proof of Right [07-07-2021(online)].pdf 2021-07-07
8 202147024578-Correspondence, Form-26_09-07-2021.pdf 2021-07-09
9 202147024578.pdf 2021-10-18
10 202147024578-FORM 3 [04-07-2022(online)].pdf 2022-07-04
11 202147024578-RELEVANT DOCUMENTS [10-01-2023(online)].pdf 2023-01-10
12 202147024578-FORM 3 [10-01-2023(online)].pdf 2023-01-10
13 202147024578-FORM 13 [10-01-2023(online)].pdf 2023-01-10
14 202147024578-PETITION UNDER RULE 138 [08-02-2023(online)].pdf 2023-02-08
15 202147024578-PETITION UNDER RULE 137 [08-02-2023(online)].pdf 2023-02-08
16 202147024578-Retyped Pages under Rule 14(1) [09-02-2023(online)].pdf 2023-02-09
17 202147024578-2. Marked Copy under Rule 14(2) [09-02-2023(online)].pdf 2023-02-09
18 202147024578-FORM 3 [14-02-2023(online)].pdf 2023-02-14
19 202147024578-FORM 3 [09-08-2023(online)].pdf 2023-08-09